- ►umich.edu [PDF] ASF Lok - The New England Journal of Medicine, 2002 - nejm.highwire.org Insulin in the dose and regimen used in this study neither delayed nor prevented
type 1 diabetes in high-risk persons. ... Monoclonal Antibody in New-Onset Type
1 Diabetes Mellitus Mechanisms that destroy beta cells in type 1 diabetes ... Cited by 1859 - Related articles - BL Direct - All 35 versions
D Ganem, AM Prince - 新英格兰医药杂志, 2004 - journal.shouxi.net Clinical and epidemiologic studies began to differentiate among various types of
acute hepatitis in the decades after World War II. The groundbreaking studies of
Krugman and colleagues in 1967 firmly established the existence of at least ... Cited by 627 - Related articles - Cached - BL Direct - All 16 versions
G Fattovich, T Stroffolini, I Zagni, F Donato - Gastroenterology, 2004 - Elsevier Emerging data indicate that the mortality rate of hepatocellular carcinoma (HCC)
associated with cirrhosis is rising in some developed countries, whereas
mortality from non-HCC complications of cirrhosis is decreasing or is ... Cited by 341 - Related articles - BL Direct - All 15 versions
- ►umich.edu [PDF] JH Hoofnagle, E Doo, TJ Liang, R Fleischer, … - Hepatology, 2007 - deepblue.lib.umich.edu Abbreviations: HBV, hepatitis B virus; NIH, National Institutes of Health; FDA,
Food and Drug Administration; AASLD, American Association for the Study of Liver
Disease; HBsAg, hepatitis B surface antigen; anti-HBs, antibody to HBsAg; ... Cited by 214 - Related articles - View as HTML - BL Direct - All 3 versions
BJ McMahon, P Holck, L Bulkow, M Snowball - Annals of internal medicine, 2001 - Am Coll Physicians Objective: To determine the incidence of and risk factors for adverse events
(hepatocellular carcinoma and end-stage liver disease) and clearance of
hepatitis B e antigen (HBeAg) and surface antigen (HBsAg) in carriers of HBV. Cited by 202 - Related articles - All 9 versions
P Lampertico, E Del Ninno, A Manzin, MF … - Hepatology, 1997 - interscience.wiley.com Short-term interferon treatment of serum hepatitis B e antigen (HBeAg)-negative
carriers with serum hepatitis B virus (HBV) DNA and histological features of
chronic hepatitis B has been largely unsuccessful. In a pilot study of ... Cited by 179 - Related articles - BL Direct - All 3 versions
RP Myers, MH Tainturier, V Ratziu, A Piton, V … - Journal of hepatology, 2003 - Elsevier Results: Two hundred and nine patients were included. Forty-one patients (20%)
had A2–A3 activity and 61 (29%) had F2–F4 fibrosis. AST and GGT (P<0.001)
were independently associated with A2–A3 activity. AST, ALT, and Actitest ... Cited by 166 - Related articles - All 7 versions
M Naito, N Hayashi, H Hagiwara, N … - Hepatology, 1994 - interscience.wiley.com We studied hepatitis C virus carriers with normal liver function to evaluate the
histological features of their livers and the replicative levels of hepatitis C
virus. Liver biopsies were performed in 22 hepatitis C virus carriers with ... Cited by 156 - Related articles - BL Direct - All 3 versions
TL Wright, JYN Lau - The Lancet, 1993 - Elsevier Hepatitis B virus: a comprehensive strategy of eliminating transmission in the
United States through universal childhood vaccination: recommendations of the
Immunization Practices Advisory Committee (ACIP). MMWR 40 RR-13 (1991), pp. ... Cited by 145 - Related articles - BL Direct - All 6 versions
G Montalto, M Cervello, L Giannitrapani, F … - ANNALS-NEW YORK ACADEMY OF SCIENCES, 2002 - interscience.wiley.com Abstract: The incidence of hepatocellular carcinoma is increasing in many
countries. The estimated number of new cases annually is over 500,000, and the
yearly incidence comprises between 2.5 and 7% of patients with liver ... Cited by 135 - Related articles - BL Direct - All 3 versions
